Results for: glaxosmithkline

GSK set to complete 13 billion pounds Novartis asset swap next week

GSK set to complete $20 billion Novartis asset swap next week

Howard Davies set to be confirmed as RBS chairman - sources

GSK's new chairman Hampton to take charge in May

Decision on Ebola mass vaccination in August at earliest: WHO

GSK and Novartis complete deals to reshape both drugmakers

FDA panel backs inhaler drug for lung disease

Glaxo, Theravance rise on FDA review of lung drug

Ky. attorney general sues GlaxoSmithKline

Drugmakers, Interpol ramp up fight against fakes

Europe dents Glaxo's Q4 profits

Biggest civil settlements for Justice Dept.

GSK cancer vaccine misses target in melanoma trial

Analysis - Bribery scandal dents Big Pharma sales in China, GSK hardest hit

Rattled by investigations, foreign firms in China beef up compliance

Lab mice breakthrough offers Alzheimer's hope

Drug safely cuts prostate cancer risk, study finds

Glaxo says China drugs sales slump on bribery probe

Amgen to pay $762M settlement over drug marketing

British medical journal slams Roche on Tamiflu

Battle to contain Ebola intensifies, Nigeria seeking volunteers

GSK-linked investigator does not dispute China charges: court

Shanghai court says trial of GSK-linked investigators set for August 8

Exclusive: Mylan near multibillion-dollar deal for Abbott drug assets -...

China indicts GSK-linked foreign investigators: Xinhua

Another fraud probe hits GSK

China fines Johnson & Johnson and others for price fixing

In Britain, a battle to spin great science into gold

Big Pharma stands to profit by cleaning out its medicine chests

Exclusive: Bayer, Novartis, others eye Merck's consumer health unit -...

GSK CEO says success of heart drug 'an open question'

China says GSK-linked trial being handled according to law

Cameron enlists ex-Goldman economist in global superbug fight

Europe's drugmakers fight off generics

Profit motive big hurdle for Ebola drugs: experts

GSK faces bribery investigation in Poland - BBC

China's new breed of whistleblowers takes on big business

Stockpiles of Roche Tamiflu drug are waste of money, review finds

Deal fever hits global pharma sector

New drug sales help boost Novartis Q1 profit